drugset / Trial / NCT03765645

Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors

NCT03765645

RandomizedParallel-groupOpen-labelPrevention

Summary

Antibiotic resistance is a very serious and dangerous situation in modern world. Judicious use of antibiotics is therefore of extreme importance not just in preventing antibiotic resistance but also it decreases cost of the treatment and prevent side-effects of the antibiotics. No randomized trial is available in literature for antibiotic prophylaxis in patient undergoing donor hepatectomy. Currently, antibiotic regimen is based on individual institutional protocol. There have been studies, comparing short course vs long dose of antibiotics in hepatectomy patients, concluding equivalent efficacy in preventing infective complications. The investigators aim at proving that 3 doses of antibiotics are equally effective in preventing infective complications, when compared to 9 doses of antibiotics, in patients undergoing donor hepatectomy. So, a randomized trial is required to study the antibiotic duration in patient undergoing donor hepatectomy.

Timeline

Start
2018-10-04
Primary completion
2020-08-31
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Piperacillin Small molecule 4.5 g Intravenous
Comparator Tazobactam Small molecule 4.5 g Intravenous

Indications

No indication recorded.